These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11984420)

  • 21. Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor alpha blockade: comment on the article by Buch et al.
    Saxne T; Larsson L; Geborek P
    Arthritis Rheum; 2004 Sep; 50(9):3049-50; author reply 3050-1. PubMed ID: 15457477
    [No Abstract]   [Full Text] [Related]  

  • 22. [Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].
    Zoń-Giebel A; Kotulska A; Giebel S; Cader SA; Kucharz EJ
    Przegl Lek; 2002; 59(11):916-8. PubMed ID: 12715722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and radiological effects of anakinra in patients with rheumatoid arthritis.
    Bresnihan B; Cobby M
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii22-8. PubMed ID: 12817092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of anakinra on clinical and radiological outcomes in rheumatoid arthritis.
    Bresnihan B
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii74-7. PubMed ID: 12379629
    [No Abstract]   [Full Text] [Related]  

  • 25. Anakinra (interleukin-1 receptor antagonist) has positive effects on function and quality of life in patients with rheumatoid arthritis.
    Kavanaugh A
    Adv Ther; 2006; 23(2):208-17. PubMed ID: 16751154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The many worlds of reducing interleukin-1.
    Dinarello CA
    Arthritis Rheum; 2005 Jul; 52(7):1960-7. PubMed ID: 15986340
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist].
    Suzuki T
    Nihon Rinsho; 2002 Dec; 60(12):2397-400. PubMed ID: 12510368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice.
    den Broeder AA; de Jong E; Franssen MJ; Jeurissen ME; Flendrie M; van den Hoogen FH
    Ann Rheum Dis; 2006 Jun; 65(6):760-2. PubMed ID: 16269431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
    Fleischmann RM; Tesser J; Schiff MH; Schechtman J; Burmester GR; Bennett R; Modafferi D; Zhou L; Bell D; Appleton B
    Ann Rheum Dis; 2006 Aug; 65(8):1006-12. PubMed ID: 16396977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Durability and rapidity of response to anakinra in patients with rheumatoid arthritis.
    Schiff MH
    Drugs; 2004; 64(22):2493-501. PubMed ID: 15516150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anakinra as a new therapeutic option in rheumatoid arthritis: clinical results and perspectives.
    Bresnihan B
    Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S32-4. PubMed ID: 14989427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
    Cohen SB; Moreland LW; Cush JJ; Greenwald MW; Block S; Shergy WJ; Hanrahan PS; Kraishi MM; Patel A; Sun G; Bear MB;
    Ann Rheum Dis; 2004 Sep; 63(9):1062-8. PubMed ID: 15082469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overview of radiologic efficacy of new treatments.
    van der Heijde DM
    Rheum Dis Clin North Am; 2004 May; 30(2):285-93, vi. PubMed ID: 15172041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biological agents for therapy of rheumatoid arthritis--overview].
    Takeuchi T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():513-6. PubMed ID: 15799409
    [No Abstract]   [Full Text] [Related]  

  • 36. [Kineret, Enbrel, Remicade and company. Recombinant drugs in rheumatoid arthritis].
    Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2003; 32(5):376-83. PubMed ID: 14526457
    [No Abstract]   [Full Text] [Related]  

  • 37. Anakinra: new preparation. Weakly effective in rheumatoid arthritis.
    Prescrire Int; 2004 Apr; 13(70):43-5. PubMed ID: 15148945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.
    Tesser J; Fleischmann R; Dore R; Bennett R; Solinger A; Joh T; Modafferi D; Schechtman J;
    J Rheumatol; 2004 Apr; 31(4):649-54. PubMed ID: 15088288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kineret: efficacy and safety in daily clinical practice: an interim analysis of the Kineret response assessment initiative (kreative) protocol.
    Langer HE; Missler-Karger B
    Int J Clin Pharmacol Res; 2003; 23(4):119-28. PubMed ID: 15224501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of interleukin-1 blockade on fatigue in rheumatoid arthritis--a pilot study.
    Omdal R; Gunnarsson R
    Rheumatol Int; 2005 Aug; 25(6):481-4. PubMed ID: 15071755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.